Palm Therapeutics, Inc.
PrivateLast Round
SAFE
Jan 25, 2024
Total Funding Raised
$1.44M
Company Overview
Palm Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a SAFE round in January 2024.
Palm Therapeutics, Inc. is a biotechnology company that provides research services and develops therapeutics to treat cancer using its proprietary small molecule drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Palm Therapeutics, Inc. Comparables
Compare Palm Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tasca Therapeutics | 84% | |
| SpringWorks Therapeutics | 69% | |
| Revolution Medicines | 69% |
For institutional investors. Book with your work email.
Palm Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Jan 25, 2024 | ||||
| Grant | Aug 30, 2021 | ||||
| Grant | Nov 23, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Palm Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| SeedFolio | SAFE |
| National Institute of Neurological Disorders and Stroke | Grant |
| Tachyon Ventures | SAFE |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 116% MoM, reaching 6.2K.
- Jan 20, 2026
Monthly visitors increased 41% MoM, from 681 to 957.
For institutional investors. Book with your work email.
Palm Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Palm Therapeutics, Inc.'s valuation, stock price, and market status.
Is Palm Therapeutics, Inc. a public or private company?
Palm Therapeutics, Inc. is a private company.
What is the current stock price of Palm Therapeutics, Inc.?
Palm Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Palm Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Palm Therapeutics, Inc. worth (valuation)?
Valuation information for Palm Therapeutics, Inc. is not publicly available.
Can I buy Palm Therapeutics, Inc. stock?
Palm Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Palm Therapeutics, Inc.'s last funding round?
Palm Therapeutics, Inc.'s most recent funding round was SAFE on January 25, 2024.
Who are the main investors in Palm Therapeutics, Inc.?
Key investors in Palm Therapeutics, Inc. include Tachyon Ventures.
Will Palm Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Palm Therapeutics, Inc..
How can I track Palm Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Palm Therapeutics, Inc.'s shares on secondary markets.